The EuroPrevall outpatient clinic study on food allergy: background and methodology

Background The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary integrated approach. To address some of the gaps in food allergy diagnosis, allergen risk management and socio‐economic impact and to...

Full description

Saved in:
Bibliographic Details
Published inAllergy (Copenhagen) Vol. 70; no. 5; pp. 576 - 584
Main Authors Fernández‐Rivas, M., Barreales, L., Mackie, A. R., Fritsche, P., Vázquez‐Cortés, S., Jedrzejczak‐Czechowicz, M., Kowalski, M. L., Clausen, M., Gislason, D., Sinaniotis, A., Kompoti, E., Le, T.‐M., Knulst, A. C., Purohit, A., Blay, F., Kralimarkova, T., Popov, T., Asero, R., Belohlavkova, S., Seneviratne, S. L., Dubakiene, R., Lidholm, J., Hoffmann‐Sommergruber, K., Burney, P., Crevel, R., Brill, M., Fernández‐Pérez, C., Vieths, S., Clare Mills, E. N., Ree, R., Ballmer‐Weber, B. K.
Format Journal Article
LanguageEnglish
Published Denmark Blackwell Publishing Ltd 01.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary integrated approach. To address some of the gaps in food allergy diagnosis, allergen risk management and socio‐economic impact and to complement the EuroPrevall population‐based surveys, a cross‐sectional study in 12 outpatient clinics across Europe was conducted. We describe the study protocol. Methods Patients referred for immediate food adverse reactions underwent a consistent and standardized allergy work‐up that comprised collection of medical history; assessment of sensitization to 24 foods, 14 inhalant allergens and 55 allergenic molecules; and confirmation of clinical reactivity and food thresholds by standardized double‐blind placebo‐controlled food challenges (DBPCFCs) to milk, egg, fish, shrimp, peanut, hazelnut, celeriac, apple and peach. Results A standardized methodology for a comprehensive evaluation of food allergy was developed and implemented in 12 outpatient clinics across Europe. A total of 2121 patients (22.6% <14 years) reporting 8257 reactions to foods were studied, and 516 DBPCFCs were performed. Conclusions This is the largest multicentre European case series in food allergy, in which subjects underwent a comprehensive, uniform and standardized evaluation including DBPCFC, by a methodology which is made available for further studies in food allergy. The analysis of this population will provide information on the different phenotypes of food allergy across Europe, will allow to validate novel in vitro diagnostic tests, to establish threshold values for major allergenic foods and to analyse the socio‐economic impact of food allergy.
AbstractList Background The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary integrated approach. To address some of the gaps in food allergy diagnosis, allergen risk management and socio-economic impact and to complement the EuroPrevall population-based surveys, a cross-sectional study in 12 outpatient clinics across Europe was conducted. We describe the study protocol. Methods Patients referred for immediate food adverse reactions underwent a consistent and standardized allergy work-up that comprised collection of medical history; assessment of sensitization to 24 foods, 14 inhalant allergens and 55 allergenic molecules; and confirmation of clinical reactivity and food thresholds by standardized double-blind placebo-controlled food challenges (DBPCFCs) to milk, egg, fish, shrimp, peanut, hazelnut, celeriac, apple and peach. Results A standardized methodology for a comprehensive evaluation of food allergy was developed and implemented in 12 outpatient clinics across Europe. A total of 2121 patients (22.6% <14 years) reporting 8257 reactions to foods were studied, and 516 DBPCFCs were performed. Conclusions This is the largest multicentre European case series in food allergy, in which subjects underwent a comprehensive, uniform and standardized evaluation including DBPCFC, by a methodology which is made available for further studies in food allergy. The analysis of this population will provide information on the different phenotypes of food allergy across Europe, will allow to validate novel in vitro diagnostic tests, to establish threshold values for major allergenic foods and to analyse the socio-economic impact of food allergy.
The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary integrated approach. To address some of the gaps in food allergy diagnosis, allergen risk management and socio-economic impact and to complement the EuroPrevall population-based surveys, a cross-sectional study in 12 outpatient clinics across Europe was conducted. We describe the study protocol. Patients referred for immediate food adverse reactions underwent a consistent and standardized allergy work-up that comprised collection of medical history; assessment of sensitization to 24 foods, 14 inhalant allergens and 55 allergenic molecules; and confirmation of clinical reactivity and food thresholds by standardized double-blind placebo-controlled food challenges (DBPCFCs) to milk, egg, fish, shrimp, peanut, hazelnut, celeriac, apple and peach. A standardized methodology for a comprehensive evaluation of food allergy was developed and implemented in 12 outpatient clinics across Europe. A total of 2121 patients (22.6% <14 years) reporting 8257 reactions to foods were studied, and 516 DBPCFCs were performed. This is the largest multicentre European case series in food allergy, in which subjects underwent a comprehensive, uniform and standardized evaluation including DBPCFC, by a methodology which is made available for further studies in food allergy. The analysis of this population will provide information on the different phenotypes of food allergy across Europe, will allow to validate novel in vitro diagnostic tests, to establish threshold values for major allergenic foods and to analyse the socio-economic impact of food allergy.
The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary integrated approach. To address some of the gaps in food allergy diagnosis, allergen risk management and socio-economic impact and to complement the EuroPrevall population-based surveys, a cross-sectional study in 12 outpatient clinics across Europe was conducted. We describe the study protocol.BACKGROUNDThe EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary integrated approach. To address some of the gaps in food allergy diagnosis, allergen risk management and socio-economic impact and to complement the EuroPrevall population-based surveys, a cross-sectional study in 12 outpatient clinics across Europe was conducted. We describe the study protocol.Patients referred for immediate food adverse reactions underwent a consistent and standardized allergy work-up that comprised collection of medical history; assessment of sensitization to 24 foods, 14 inhalant allergens and 55 allergenic molecules; and confirmation of clinical reactivity and food thresholds by standardized double-blind placebo-controlled food challenges (DBPCFCs) to milk, egg, fish, shrimp, peanut, hazelnut, celeriac, apple and peach.METHODSPatients referred for immediate food adverse reactions underwent a consistent and standardized allergy work-up that comprised collection of medical history; assessment of sensitization to 24 foods, 14 inhalant allergens and 55 allergenic molecules; and confirmation of clinical reactivity and food thresholds by standardized double-blind placebo-controlled food challenges (DBPCFCs) to milk, egg, fish, shrimp, peanut, hazelnut, celeriac, apple and peach.A standardized methodology for a comprehensive evaluation of food allergy was developed and implemented in 12 outpatient clinics across Europe. A total of 2121 patients (22.6% <14 years) reporting 8257 reactions to foods were studied, and 516 DBPCFCs were performed.RESULTSA standardized methodology for a comprehensive evaluation of food allergy was developed and implemented in 12 outpatient clinics across Europe. A total of 2121 patients (22.6% <14 years) reporting 8257 reactions to foods were studied, and 516 DBPCFCs were performed.This is the largest multicentre European case series in food allergy, in which subjects underwent a comprehensive, uniform and standardized evaluation including DBPCFC, by a methodology which is made available for further studies in food allergy. The analysis of this population will provide information on the different phenotypes of food allergy across Europe, will allow to validate novel in vitro diagnostic tests, to establish threshold values for major allergenic foods and to analyse the socio-economic impact of food allergy.CONCLUSIONSThis is the largest multicentre European case series in food allergy, in which subjects underwent a comprehensive, uniform and standardized evaluation including DBPCFC, by a methodology which is made available for further studies in food allergy. The analysis of this population will provide information on the different phenotypes of food allergy across Europe, will allow to validate novel in vitro diagnostic tests, to establish threshold values for major allergenic foods and to analyse the socio-economic impact of food allergy.
The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary integrated approach. To address some of the gaps in food allergy diagnosis, allergen risk management and socio-economic impact and to complement the EuroPrevall population-based surveys, a cross-sectional study in 12 outpatient clinics across Europe was conducted. We describe the study protocol. Patients referred for immediate food adverse reactions underwent a consistent and standardized allergy work-up that comprised collection of medical history; assessment of sensitization to 24 foods, 14 inhalant allergens and 55 allergenic molecules; and confirmation of clinical reactivity and food thresholds by standardized double-blind placebo-controlled food challenges (DBPCFCs) to milk, egg, fish, shrimp, peanut, hazelnut, celeriac, apple and peach. A standardized methodology for a comprehensive evaluation of food allergy was developed and implemented in 12 outpatient clinics across Europe. A total of 2121 patients (22.6% <14 years) reporting 8257 reactions to foods were studied, and 516 DBPCFCs were performed. This is the largest multicentre European case series in food allergy, in which subjects underwent a comprehensive, uniform and standardized evaluation including DBPCFC, by a methodology which is made available for further studies in food allergy. The analysis of this population will provide information on the different phenotypes of food allergy across Europe, will allow to validate novel in vitro diagnostic tests, to establish threshold values for major allergenic foods and to analyse the socio-economic impact of food allergy.
Background The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary integrated approach. To address some of the gaps in food allergy diagnosis, allergen risk management and socio‐economic impact and to complement the EuroPrevall population‐based surveys, a cross‐sectional study in 12 outpatient clinics across Europe was conducted. We describe the study protocol. Methods Patients referred for immediate food adverse reactions underwent a consistent and standardized allergy work‐up that comprised collection of medical history; assessment of sensitization to 24 foods, 14 inhalant allergens and 55 allergenic molecules; and confirmation of clinical reactivity and food thresholds by standardized double‐blind placebo‐controlled food challenges (DBPCFCs) to milk, egg, fish, shrimp, peanut, hazelnut, celeriac, apple and peach. Results A standardized methodology for a comprehensive evaluation of food allergy was developed and implemented in 12 outpatient clinics across Europe. A total of 2121 patients (22.6% <14 years) reporting 8257 reactions to foods were studied, and 516 DBPCFCs were performed. Conclusions This is the largest multicentre European case series in food allergy, in which subjects underwent a comprehensive, uniform and standardized evaluation including DBPCFC, by a methodology which is made available for further studies in food allergy. The analysis of this population will provide information on the different phenotypes of food allergy across Europe, will allow to validate novel in vitro diagnostic tests, to establish threshold values for major allergenic foods and to analyse the socio‐economic impact of food allergy.
Author Kowalski, M. L.
Hoffmann‐Sommergruber, K.
Brill, M.
Fernández‐Rivas, M.
Vázquez‐Cortés, S.
Le, T.‐M.
Blay, F.
Barreales, L.
Belohlavkova, S.
Seneviratne, S. L.
Ballmer‐Weber, B. K.
Popov, T.
Dubakiene, R.
Kralimarkova, T.
Clare Mills, E. N.
Clausen, M.
Purohit, A.
Lidholm, J.
Fritsche, P.
Crevel, R.
Jedrzejczak‐Czechowicz, M.
Gislason, D.
Vieths, S.
Asero, R.
Burney, P.
Fernández‐Pérez, C.
Mackie, A. R.
Knulst, A. C.
Sinaniotis, A.
Kompoti, E.
Ree, R.
Author_xml – sequence: 1
  givenname: M.
  surname: Fernández‐Rivas
  fullname: Fernández‐Rivas, M.
  organization: IdISSC
– sequence: 2
  givenname: L.
  surname: Barreales
  fullname: Barreales, L.
  organization: IdISSC
– sequence: 3
  givenname: A. R.
  surname: Mackie
  fullname: Mackie, A. R.
  organization: Norwich Research Park
– sequence: 4
  givenname: P.
  surname: Fritsche
  fullname: Fritsche, P.
  organization: University Hospital Zürich
– sequence: 5
  givenname: S.
  surname: Vázquez‐Cortés
  fullname: Vázquez‐Cortés, S.
  organization: IdISSC
– sequence: 6
  givenname: M.
  surname: Jedrzejczak‐Czechowicz
  fullname: Jedrzejczak‐Czechowicz, M.
  organization: Medical University of Lodz
– sequence: 7
  givenname: M. L.
  surname: Kowalski
  fullname: Kowalski, M. L.
  organization: Medical University of Lodz
– sequence: 8
  givenname: M.
  surname: Clausen
  fullname: Clausen, M.
  organization: Landspitali University Hospital
– sequence: 9
  givenname: D.
  surname: Gislason
  fullname: Gislason, D.
  organization: Landspitali University Hospital
– sequence: 10
  givenname: A.
  surname: Sinaniotis
  fullname: Sinaniotis, A.
  organization: Laiko General Hospital
– sequence: 11
  givenname: E.
  surname: Kompoti
  fullname: Kompoti, E.
  organization: Laiko General Hospital
– sequence: 12
  givenname: T.‐M.
  surname: Le
  fullname: Le, T.‐M.
  organization: University Medical Center Utrecht
– sequence: 13
  givenname: A. C.
  surname: Knulst
  fullname: Knulst, A. C.
  organization: University Medical Center Utrecht
– sequence: 14
  givenname: A.
  surname: Purohit
  fullname: Purohit, A.
  organization: University Hospital
– sequence: 15
  givenname: F.
  surname: Blay
  fullname: Blay, F.
  organization: University Hospital
– sequence: 16
  givenname: T.
  surname: Kralimarkova
  fullname: Kralimarkova, T.
  organization: Medical University Sofia
– sequence: 17
  givenname: T.
  surname: Popov
  fullname: Popov, T.
  organization: Medical University Sofia
– sequence: 18
  givenname: R.
  surname: Asero
  fullname: Asero, R.
  organization: Clinica San Carlo
– sequence: 19
  givenname: S.
  surname: Belohlavkova
  fullname: Belohlavkova, S.
  organization: Charles University
– sequence: 20
  givenname: S. L.
  surname: Seneviratne
  fullname: Seneviratne, S. L.
  organization: Central Manchester and Manchester Children's University Hospitals NHS Trust
– sequence: 21
  givenname: R.
  surname: Dubakiene
  fullname: Dubakiene, R.
  organization: Vilnius University
– sequence: 22
  givenname: J.
  surname: Lidholm
  fullname: Lidholm, J.
  organization: Thermo Fisher Scientific
– sequence: 23
  givenname: K.
  surname: Hoffmann‐Sommergruber
  fullname: Hoffmann‐Sommergruber, K.
  organization: Medical University of Vienna
– sequence: 24
  givenname: P.
  surname: Burney
  fullname: Burney, P.
  organization: Imperial College London
– sequence: 25
  givenname: R.
  surname: Crevel
  fullname: Crevel, R.
  organization: Colworth Science Park
– sequence: 26
  givenname: M.
  surname: Brill
  fullname: Brill, M.
  organization: VBC Genomics Biosciences Research GmbH
– sequence: 27
  givenname: C.
  surname: Fernández‐Pérez
  fullname: Fernández‐Pérez, C.
  organization: IdISSC
– sequence: 28
  givenname: S.
  surname: Vieths
  fullname: Vieths, S.
  organization: Paul Ehrlich Institute
– sequence: 29
  givenname: E. N.
  surname: Clare Mills
  fullname: Clare Mills, E. N.
  organization: The University of Manchester
– sequence: 30
  givenname: R.
  surname: Ree
  fullname: Ree, R.
  organization: University of Amsterdam
– sequence: 31
  givenname: B. K.
  surname: Ballmer‐Weber
  fullname: Ballmer‐Weber, B. K.
  organization: University Hospital Zürich
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25640688$$D View this record in MEDLINE/PubMed
BookMark eNqN0UtLw0AQAOBFKvahB_-ABLx4SbuPbHbXWyn1AQEF6zlsNpM2NcnWPJT8e9e2evDkwrDLzMfAzozRoLIVIHRJ8JS4M9NFMSWUS36CRoQp6Sul-ACNMMHcDziTQzRumi3GWFCFz9CQ8jDAoZQj9LLagLfsavtcw4fr49mu3ek2h6r1TJFXufGatkt7z1ZeZm3qOQP1ur_1Em3e1rXtKpdzUUK7sakt7Lo_R6eZLhq4ON4T9Hq3XC0e_Ojp_nExj_wtE5L7ihqFTcKpMQREhg3lidGauURKFcEBCJMRDAzTjDIJISdU0IQBKKMTnLEJujn03dX2vYOmjcu8MVAUugLbNTEJRchCHjD6H0ooEYJIR6__0K3t6sp9xKlQCUk5Zk5dHVWXlJDGuzovdd3HP5N1YHYAn3kB_W-d4Ph7ZbEbY7xfWTyPov2DfQFPkIlq
ContentType Journal Article
Copyright 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Copyright © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Copyright_xml – notice: 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
– notice: Copyright © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
DBID CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
F1W
H95
L.G
DOI 10.1111/all.12585
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
ASFA: Aquatic Sciences and Fisheries Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
Aquatic Science & Fisheries Abstracts (ASFA) Professional
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
ASFA: Aquatic Sciences and Fisheries Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1398-9995
EndPage 584
ExternalDocumentID 3645566561
25640688
ALL12585
Genre article
Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GeographicLocations Europe
ANE, Europe
GeographicLocations_xml – name: Europe
– name: ANE, Europe
GrantInformation_xml – fundername: European Commission under the 6th Framework Programme
  funderid: FOOD‐CT‐2005‐514000
– fundername: Biotechnology and Biological Sciences Research Council
  grantid: BBS/E/F/00041800
GroupedDBID .3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
2WC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOETA
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TR2
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
Y6R
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAMMB
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
F1W
H95
L.G
ID FETCH-LOGICAL-j3785-92c90cb52cc1e7f0c25bcaa352cd29104e7cf10e302f238e651272b3ee9cab0f3
IEDL.DBID DR2
ISSN 0105-4538
1398-9995
IngestDate Fri Jul 11 12:22:16 EDT 2025
Fri Jul 11 02:24:16 EDT 2025
Sat Jul 26 02:19:49 EDT 2025
Mon Jul 21 05:49:21 EDT 2025
Wed Jan 22 17:04:02 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords cross-sectional
outpatient clinic
EuroPrevall
food allergy
methods
Language English
License 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-j3785-92c90cb52cc1e7f0c25bcaa352cd29104e7cf10e302f238e651272b3ee9cab0f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25640688
PQID 1669782503
PQPubID 34098
PageCount 9
ParticipantIDs proquest_miscellaneous_1676365432
proquest_miscellaneous_1671217718
proquest_journals_1669782503
pubmed_primary_25640688
wiley_primary_10_1111_all_12585_ALL12585
PublicationCentury 2000
PublicationDate May 2015
PublicationDateYYYYMMDD 2015-05-01
PublicationDate_xml – month: 05
  year: 2015
  text: May 2015
PublicationDecade 2010
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
– name: Zurich
PublicationTitle Allergy (Copenhagen)
PublicationTitleAlternate Allergy
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 1993; 14
2010; 65
2009; 64
2013; 23
2007; 120
2014; 69
2008; 46
2005; 43
2007; 51
2007; 62
2008; 63
2005; 60
2008; 52
2013; 131
2009; 395
2002; 109
2014; 111
2008; 121
2012; 67
2012; 56
2003; 112
2010; 6
References_xml – volume: 121
  start-page: 1507
  year: 2008
  end-page: 1508
  article-title: Outcome and safety of double‐blind placebo‐controlled food challenges in 111 patients sensitized to lipid transfer proteins
  publication-title: J Allergy Clin Immunol
– volume: 112
  start-page: 789
  year: 2003
  end-page: 795
  article-title: Clinically relevant peach allergy is related to peach lipid transfer protein, Pru p 3, in the Spanish population
  publication-title: J Allergy Clin Immunol
– volume: 56
  start-page: 1708
  year: 2012
  end-page: 1714
  article-title: High fat food increases gastric residence and thus thresholds for objective symptoms in allergic patients
  publication-title: Mol Nutr Food Res
– volume: 120
  start-page: 638
  year: 2007
  end-page: 646
  article-title: The prevalence of food allergy: a meta‐analysis
  publication-title: J Allergy Clin Immunol
– volume: 60
  start-page: 996
  year: 2005
  end-page: 1003
  article-title: A framework for measuring costs to society of IgE‐mediated food allergy
  publication-title: Allergy
– volume: 43
  start-page: 1321
  year: 2005
  end-page: 1326
  article-title: Protein microarrays for the diagnosis of allergic diseases: state‐of‐the‐art and future development
  publication-title: Clin Chem Lab Med
– volume: 111
  start-page: 12
  year: 2014
  end-page: 22
  article-title: Effectiveness and safety of orally administered immunotherapy for food allergies: a systematic review and meta‐analysis
  publication-title: Br J Nutr
– volume: 62
  start-page: 733
  year: 2007
  end-page: 737
  article-title: A framework for measuring the social impact of food allergy across Europe: a EuroPrevall state of the art paper
  publication-title: Allergy
– volume: 46
  start-page: S2
  issue: Suppl 10
  year: 2008
  end-page: S5
  article-title: Food allergy: a clinician's criteria for including sera in a serum bank
  publication-title: Food Chem Toxicol
– volume: 69
  start-page: 1008
  year: 2014
  end-page: 1025
  article-title: EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy
  publication-title: Allergy
– volume: 63
  start-page: 597
  year: 2008
  end-page: 609
  article-title: Thresholds for food allergens and their value to different stakeholders
  publication-title: Allergy
– volume: 121
  start-page: 1210
  year: 2008
  end-page: 1218
  article-title: The prevalence of plant food allergies: a systematic review
  publication-title: J Allergy Clin Immunol
– volume: 52
  start-page: S159
  issue: Suppl 2
  year: 2008
  end-page: S165
  article-title: Coordinated and standardized production, purification and characterization of natural and recombinant food allergens to establish a food allergen library
  publication-title: Mol Nutr Food Res
– volume: 395
  start-page: 25
  year: 2009
  end-page: 35
  article-title: Food allergen protein families and their structural characteristics and application in component‐resolved diagnosis: new data from the EuroPrevall project
  publication-title: Anal Bioanal Chem
– volume: 69
  start-page: 834
  year: 2014
  end-page: 844
  article-title: Disease‐specific health‐related quality of life instruments for IgE‐mediated food allergy
  publication-title: Allergy
– volume: 69
  start-page: 62
  year: 2014
  end-page: 75
  article-title: EAACI Food Allergy and Anaphylaxis Guidelines Group. The epidemiology of food allergy in Europe: a systematic review and meta‐analysis
  publication-title: Allergy
– volume: 46
  start-page: S12
  issue: Suppl 10
  year: 2008
  end-page: S14
  article-title: The serum bank of EuroPrevall – the prevalence, cost and basis of food allergy across Europe
  publication-title: Food Chem Toxicol
– volume: 62
  start-page: 717
  year: 2007
  end-page: 722
  article-title: The prevalence, cost and basis of food allergy across Europe
  publication-title: Allergy
– volume: 65
  start-page: 482
  year: 2010
  end-page: 490
  article-title: The multinational birth cohort of EuroPrevall: background, aims and methods
  publication-title: Allergy
– volume: 51
  start-page: 135
  year: 2007
  end-page: 147
  article-title: IgE‐mediated food allergy diagnosis: current status and new perspectives
  publication-title: Mol Nutr Food Res
– volume: 131
  start-page: 164
  year: 2013
  end-page: 171
  article-title: Kiwifruit allergy across Europe: clinical manifestation and IgE recognition patterns to kiwifruit allergens
  publication-title: J Allergy Clin Immunol
– volume: 67
  start-page: 107
  year: 2012
  end-page: 113
  article-title: Development of a standardized low dose double‐blind placebo‐controlled challenge vehicle for the EuroPrevall project
  publication-title: Allergy
– volume: 52
  start-page: S157
  issue: Suppl 2
  year: 2008
  end-page: S158
  article-title: EuroPrevall food allergen library
  publication-title: Mol Nutr Food Res
– volume: 6
  start-page: S1
  issue: Suppl
  year: 2010
  end-page: S58
  article-title: Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID‐sponsored expert panel
  publication-title: J Allergy Clin Immunol.
– volume: 64
  start-page: 1493
  year: 2009
  end-page: 1497
  article-title: The EuroPrevall surveys on the prevalence of food allergies in children and adults: background and study methodology
  publication-title: Allergy
– volume: 23
  start-page: 757
  year: 2013
  end-page: 762
  article-title: Health sector costs of self‐reported food allergy in Europe: a patient‐based cost of illness study
  publication-title: Eur J Public Health
– volume: 14
  start-page: 48
  issue: Suppl
  year: 1993
  end-page: 82
  article-title: The European Academy of Allergology and Clinical Immunology
  publication-title: Allergy
– volume: 109
  start-page: 24
  year: 2002
  end-page: 30
  article-title: Factors affecting the determination of threshold doses for allergenic foods: how much is too much?
  publication-title: J Allergy Clin Immunol
– volume: 131
  start-page: 14
  year: 2013
  end-page: 22
  article-title: Can we produce true tolerance in patients with food allergy?
  publication-title: J Allergy Clin Immunol.
SSID ssj0007290
Score 2.3512726
Snippet Background The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a...
The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a multidisciplinary...
Background The EuroPrevall project aimed to develop effective management strategies in food allergy through a suite of interconnected studies and a...
SourceID proquest
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 576
SubjectTerms Ambulatory Care Facilities
Arachis hypogaea
Cross-Sectional Studies
cross‐sectional
Decapoda
Epidemiology
Europe - epidemiology
EuroPrevall
Female
Food allergies
food allergy
Food Hypersensitivity - diagnosis
Food Hypersensitivity - epidemiology
Humans
Immunologic Tests - methods
Immunologic Tests - standards
Male
methods
outpatient clinic
Prunus
Research Design
Title The EuroPrevall outpatient clinic study on food allergy: background and methodology
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.12585
https://www.ncbi.nlm.nih.gov/pubmed/25640688
https://www.proquest.com/docview/1669782503
https://www.proquest.com/docview/1671217718
https://www.proquest.com/docview/1676365432
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5KD-LF9yNaZQUPXlKS3U220VMRi0jrQS30IITd7UawJZE-Dvrrnd2k9YGIeAiE7CwkmZmdb2fnAXDKqaBcxJEvuQp8rmLuJ0y2fKlEGCq0V5lrBtO7ja_7_GYQDWpwsciFKetDLB1uVjPcem0VXKrpJyWX43ETrXPLJpjbWC0LiO4-SkeJyr-C-MHnqNVVVSEbxbOc-ROq_ApSnZXprMPj4v3K4JJRcz5TTf32rXTjPz9gA9Yq9EnapbhsQs3kW7DSq87Xt-EepYZYB72t7IQzSTGfVZVXSZlDSVw9WlLkJCuKIbGdWCZPr-dEST2yGSI5PsOrbEztXPY70O9cPVxe-1XbBf-ZiVbkJ1QngVYR1To0Igs0jZSWEpGaHlJEF9wInYWBYQHN0OCbGDGDoIoZk2ipgoztQj0vcrMPJEaqJGO4oEYZN4hFEdAFQyFRcMwwZMKDxoIBaaU70zSMY9zaIjRjHpwsh1Hq7VGGzE0xtzQixM0UGtZfaWJmU2epB3slc9OXsoRHikCP23Y7Hpw5Fi0HFnsi_H2pY07a7nbdzcHfSQ9hFXFVVMZFNqA-m8zNEWKXmTp2QvoOMG3pIA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZ4SMCF92MwIEgcuHRqm7RZEZcJMQ3YduAhcUFVkqVIbGoRtAf49ThpNx5CCHGoVDWu1MZ2_NmJbYBD5nOf8TBwBJOuw2TInIiKpiMk9zyJ9iqxzWB6_bBzyy7ugrspOBnnwpT1ISYBN6MZdr02Cm4C0p-0XIxGDTTPzWAaZk1Hb-tQXX0Uj-JVhAURhMNQr6u6QuYcz-TVn3DlV5hq7Ux7Ce7HX1geLxk2ilw21Nu34o3__YVlWKwAKGmVErMCUzpdhbletcW-BtcoOMTE6E1xJ3yTZEVeFV8lZRolsSVpSZaSJMsGxDRjeX54PSZSqKFJEknxGV5lb2obtV-H2_bZzWnHqTovOI-UNwMn8lXkKhn4SnmaJ67yA6mEQLCmBj4CDKa5SjxXU9dP0OZrnH3kuaRaR0pIN6EbMJNmqd4CEiJVlFBcU4OEaYSjiOncARcoO3rgUV6D-pgDcaU-L7EXhujdIjqjNTiYDKPgm90MkeqsMDTcQ38KbeuvNCE12bN-DTZL7sZPZRWPGLEeMx13anBkeTQZGLtFOH2xZU7c6nbtzfbfSfdhvnPT68bd8_7lDiwgzArKY5J1mMmfC72LUCaXe1Zi3wHEpu07
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwED51Rar2AgPG6ChgJB54SZXYjt3AU7VRja2tJmBSHyZFtmMjsSmpuvQBfv3OTtoNhBDiIVIU21KSu_N9Pvu-A3jLqaRcijRSXMcR14JHGVOjSGmZJBr9lQvFYGZzcXLBTxfpogMfNrkwDT_ENuDmLSPM197Al4W7Z-Tq-nqI3nmU7sADLuKRV-njz3fcUbINsCCAiDiadUsr5I_xbIf-CVb-ilKDm5k8gsvNCzanS66G61oPzc_fuBv_8wv24GELP8m40ZfH0LHlE-jN2g32p_AF1Yb4CL2ndsKRpFrXLfUqaZIoSSCkJVVJXFUVxJdiWX378Z5oZa58ikiJz_BqKlOHmP0-XEw-fj06idq6C9F3JkdplFGTxUan1JjEShcbmmqjFEI1U1CEF9xK45LYspg69PhWIGiQVDNrM6N07Ngz6JZVaZ8DEdgrcwxn1NRxi2AUEV1cSIWaY4uEyT4MNgLIW-O5yRMhcG2L2Iz14c22GdXe72Wo0lZr30cmuJpCz_rXPoL53Fnah4NGuPmy4fDIEelxX2-nD--CiLYNm0UR_r48CCcfT6fh5vDfu76G3vnxJJ9-mp-9gF3EWGlzRnIA3Xq1ti8Rx9T6VdDXWyhw6_M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+EuroPrevall+outpatient+clinic+study+on+food+allergy%3A+background+and+methodology&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Fern%C3%A1ndez-Rivas%2C+M&rft.au=Barreales%2C+L&rft.au=Mackie%2C+A+R&rft.au=Fritsche%2C+P&rft.date=2015-05-01&rft.issn=1398-9995&rft.eissn=1398-9995&rft.volume=70&rft.issue=5&rft.spage=576&rft_id=info:doi/10.1111%2Fall.12585&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon